loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 28339 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Chirogate International

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Chirogate International (1)

    filter

    01 UNOPROSTONE ISOPROPYL (1)

    filter

    01 Taiwan (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CHIROGATE INTERNATIONAL INC

    Contact Supplier
    • FDA
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.
    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    UNOPROSTONE ISOPROPYL

    PDF Supplier PDF
    URL Supplier Web Content
    28339
    Active
    2014-06-17
    Complete
    2014-08-20
    2014-06-09
    II
    Chirogate CB

    CPhI Japan

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 28339 of Chirogate International Inc

    Looking for Drug Master Files (DMF) for 28339 of Chirogate International Inc 1

    20

    Chirogate International Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA.

    They are recognized for Chirogate is a professional Prostaglandin manufacturer.

    One of their notable products is UNOPROSTONE ISOPROPYL, with a corresponding US DMF Number 28339.

    Remarkably, this DMF maintains an Active status since its submission on June 17, 2014, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on June 09, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY